Tenax Therapeutics (TENX) Accumulated Depreciation & Amortization (2012 - 2021)
Tenax Therapeutics recorded quarterly Accumulated Depreciation & Amortization of $57803.0 in Q3 2021, down 5.0% quarter-over-quarter from $60843.0 in Q2 2021, and down 2.67% year-over-year from $59389.0 in Q3 2020.
Tenax Therapeutics' Accumulated Depreciation & Amortization history runs 9 years deep, the most recent figure standing at $57803.0 for Q3 2021.
- In Q3 2021, Accumulated Depreciation & Amortization fell 2.67% year-over-year to $57803.0; the TTM figure through Sep 2021 stood at $57803.0 (down 2.67% YoY), while the FY2020 annual figure was $60368.0, down 70.45% from the prior year.
- Accumulated Depreciation & Amortization came in at $57803.0 for Q3 2021 at Tenax Therapeutics, down from $60843.0 in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $575081.0 in Q2 2017 to a low of $57803.0 in Q3 2021.
- A 5-year average of $306727.3 and a median of $204302.0 in 2019 frame the typical range for Accumulated Depreciation & Amortization.
- Across the five-year window, Accumulated Depreciation & Amortization gained 1.6% in 2018 and slumped 70.74% in 2020, its largest moves.
- Tenax Therapeutics' Accumulated Depreciation & Amortization stood at $564106.0 in 2017, then rose by 1.6% to $573121.0 in 2018, then slumped by 64.35% to $204302.0 in 2019, then tumbled by 70.45% to $60368.0 in 2020, then retreated by 4.25% to $57803.0 in 2021.
- According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $57803.0, $60843.0, and $59953.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 57,803.00 |
| Sep 30, 2021 | 57,803.00 |
| Jun 30, 2021 | 60,843.00 |
| Jun 30, 2021 | 60,843.00 |
| Mar 31, 2021 | 59,953.00 |
| Mar 31, 2021 | 59,953.00 |
| Dec 31, 2020 | 60,368.00 |
| Dec 31, 2020 | 60,368.00 |
| Sep 30, 2020 | 59,389.00 |
| Sep 30, 2020 | 59,389.00 |
| Jun 30, 2020 | 60,905.00 |
| Jun 30, 2020 | 60,905.00 |
| Mar 31, 2020 | 74,785.00 |
| Mar 31, 2020 | 74,785.00 |
| Dec 31, 2019 | 204,302.00 |
| Dec 31, 2019 | 204,302.00 |
| Sep 30, 2019 | 202,993.00 |
| Sep 30, 2019 | 202,993.00 |
| Jun 30, 2019 | 201,684.00 |
| Jun 30, 2019 | 201,684.00 |
| Mar 31, 2019 | 219,897.00 |
| Mar 31, 2019 | 219,897.00 |
| Dec 31, 2018 | 573,121.00 |
| Dec 31, 2018 | 573,121.00 |
| Sep 30, 2018 | 571,679.00 |
| Sep 30, 2018 | 571,679.00 |
| Jun 30, 2018 | 569,547.00 |
| Jun 30, 2018 | 569,547.00 |
| Mar 31, 2018 | 566,680.00 |
| Mar 31, 2018 | 566,680.00 |
| Dec 31, 2017 | 564,106.00 |
| Dec 31, 2017 | 564,106.00 |
| Sep 30, 2017 | 573,025.00 |
| Sep 30, 2017 | 573,025.00 |
| Jun 30, 2017 | 575,081.00 |
| Jun 30, 2017 | 575,081.00 |
| Mar 31, 2017 | 571,657.00 |
| Mar 31, 2017 | 571,657.00 |
| Dec 31, 2016 | 567,625.00 |
| Dec 31, 2016 | 567,625.00 |
| Sep 30, 2016 | 604,395.00 |
| Sep 30, 2016 | 604,395.00 |
| Jun 30, 2016 | 758,315.00 |
| Jun 30, 2016 | 758,315.00 |
| Dec 31, 2015 | 748,604.00 |
| Dec 31, 2015 | 748,604.00 |
| Apr 30, 2013 | 828,752.00 |
| Apr 30, 2013 | 828,752.00 |
| Jan 31, 2013 | 999,003.00 |
| Jan 31, 2013 | 999,003.00 |
| Oct 31, 2012 | 976,073.00 |
| Oct 31, 2012 | 976,073.00 |
| Jul 31, 2012 | 977,593.00 |
| Jul 31, 2012 | 977,593.00 |
| Apr 30, 2012 | 953,565.00 |
| Apr 30, 2012 | 953,565.00 |